New Rules Could End Thousands of Clinical Trials

New federal rules could shut down nearly 5,000 clinical trials—including 1,000 cancer studies—by letting political appointees, not scientists, decide grant funding. Critics warn this undermines peer review, risks patient care, and could halt vital research on heart disease, pediatric care, and veteran health. The Office of Management and Budget claims it’s targeting “woke” agendas and foreign collaborations, but scientists fear it’ll destabilize medical progress and endanger tens of thousands of patients. With half of NIH trials potentially at risk, the public comment period ends soon—before a final decision could reshape U.S. medical research by October. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/30d1f1cafbc20269